Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD of ORAMED PHARMACEUTICALS INC. from Q3 2019 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
-
Summary
-
Oramed Pharmaceuticals Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and change rate from Q3 2019 to Q3 2025.
- Oramed Pharmaceuticals Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending September 30, 2025 was $202M, a 30.1% increase year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)